Alexis Garcia, PharmD, senior director of business development at Tabula Rasa HealthCare, explains the importance of up-to-date data when implementing medication therapy management programs.
Obtaining timely data and encouraging patient engagement are crucial to successful medication therapy management programs, said Alexis Garcia, PharmD, senior director of business development at Tabula Rasa HealthCare.
Transcript
Are different demographics more susceptible to the effects of cytochrome P450 (CYP450) enzymes?
So everybody is different and everybody can have a different response to medications based on their genetic differences. So race and ethnicity can play a role in adverse drug events. You know, some people may be ultra metabolizers. Some may be poor metabolizers. And ultimately that's going to affect the way that they process those medications.
If medication therapy management (MTM) programs help with these issues, what are some of the barriers payers face in implementing these programs?
I think some of the biggest barriers to implementing real successful MTM programs are timely data. So you want to make sure that when you're speaking to a patient that you have the most up to date information for that patient that allows you to have more impactful interventions or recommendations with that patient, but also patient engagement. So one, how can you get ahold of this patient to talk to them about their medications and establishing that trust with the patient, that you are a clinician calling on their behalf and that you do want to help them? Make sure that they are on the most safe medications and really getting optimal use from the medications that they're taking.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More